Podcasts

Episode 19 | Consider Every Trial as a TeleTrial

A/Prof Craig Underhill, Prof Sabe Sabesan and patient advocate Alexandra Golledge discuss how TeleTrials bring new therapies to patients sooner to positively impact the future of trials in Australia.

Consider Every Trial as a TeleTrial

Episode Summary

A/Prof Craig Underhill, Prof Sabe Sabesan and patient advocate Alexandra Golledge discuss how TeleTrials bring new therapies to patients sooner. New frameworks are increasing clinical trial participation and co ordination between trial and satellite centres is improving. Imaging, blood tests and examinations can be done at a local level, without extensive travel that was deemed necessary in the past. Barriers and facilitators and a unique insight into the patient benefits are discussed between Alexandra Golledge, Prof Sabe Sabesan and A/Prof Craig Underhill. Incentive funding and harmonising governance requirements for TeleTrials in Australia will help solve many of these issues and continue to transform the way trials are managed. The benefits for patients and their families are clear and positively impact the future of trials in Australia.

 

Resources:

 

Supported by Takeda

 

Disclaimer: The opinions, beliefs and viewpoints expressed by the various authors and participants contained in this message do not necessarily reflect the opinions, beliefs and viewpoints of TOGA or official policies of TOGA. Dosage & administration of any treatments mentioned during TOGA medical education may differ between Regions. Please refer to your local prescribing information for further details.

Show Hosts

This episode’s host are:

  • Alexandra Golledge, patient advocate, teletrials participant and lung cancer survivor
  • Prof Sabe Sabesan, Medical Oncologist, ICON Cancer Centre Townsville; Co-Chair, Australian Teletrial Program and initial teletrials pilot 2017-2020
  • A/Prof Craig Underhill, Medical Oncologist, Border Medical Oncology and Haematology Albury/Wodonga

Play Episode 19 | Consider Every Trial as a TeleTrial

More Podcasts

A conversation with Associate Professor Tom John and Professor Ben Solomon where they discuss the increased survival benefits for patients with oncogene driven lung cancer
In this Podcast, Mark Scott talks with Alexandra Golledge about her challenges in diagnosis, searching for the best treatments available, living in a regional area
Prof Nick Pavlakis and Prof Emily Stone join discuss the remarkable advances in screening, diagnosing and treating lung cancer that occurred during 2020.
Dorothy Keefe, CEO of Cancer Australia and Mark Scott discuss the COVID impact on diagnosing and treating lung cancer patients.
A fireside chat with Prunella Blinman, Shankar Siva and our three Preceptees: Anna Lawless, Abhijit Pal and Melanie Rabbets about their experiences, their learnings, what
In this episode, Prof Anna Nowak and A/Prof Steven Kao discuss the emerging treatments for mesothelioma patients and the DREAM3R trial.